Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI

The selection of proper candidates for prostate biopsy after magnetic resonance imaging (MRI) has usually been studied in the overall population with suspected prostate cancer (PCa). However, the performance of these tools can change regarding the Prostate Imaging-Reporting and Data System (PI-RADS)...

Descripción completa

Detalles Bibliográficos
Autores: Campistol i Torres, Miriam|||0000-0002-3212-3473, Morote Robles, Juan|||0000-0002-2168-323X, Triquell, Marina|||0000-0003-3881-8177, Regis, Lucas|||0000-0001-7121-1946, Celma, Ana|||0000-0002-3128-3811, de Torres, Inés|||0000-0002-5495-9140, Semidey Raven, Maria Eugenia|||0000-0001-8539-9265, Mast, Richard|||0000-0001-6005-800X, Fàbrega-Santamaria, Anna|||0000-0002-3866-2291, Planas Morin, Jacques|||0000-0002-0222-584X, Trilla Herrera, Enrique|||0000-0001-9401-0872
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:292218
Acceso en línea:https://ddd.uab.cat/record/292218
https://dx.doi.org/urn:doi:10.3390/cancers14112702
Access Level:acceso abierto
Palabra clave:Clinically significant prostate cancer
PSA density
Proclarix
MRI-ERSPC
Magnetic resonance imaging
id ES_ddf8d6a8de8dc2c6c227d0343ff6f607
oai_identifier_str oai:ddd.uab.cat:292218
network_acronym_str ES
network_name_str España
repository_id_str
spelling Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRICampistol i Torres, Miriam|||0000-0002-3212-3473Morote Robles, Juan|||0000-0002-2168-323XTriquell, Marina|||0000-0003-3881-8177Regis, Lucas|||0000-0001-7121-1946Celma, Ana|||0000-0002-3128-3811de Torres, Inés|||0000-0002-5495-9140Semidey Raven, Maria Eugenia|||0000-0001-8539-9265Mast, Richard|||0000-0001-6005-800XFàbrega-Santamaria, Anna|||0000-0002-3866-2291Planas Morin, Jacques|||0000-0002-0222-584XTrilla Herrera, Enrique|||0000-0001-9401-0872Clinically significant prostate cancerPSA densityProclarixMRI-ERSPCMagnetic resonance imagingThe selection of proper candidates for prostate biopsy after magnetic resonance imaging (MRI) has usually been studied in the overall population with suspected prostate cancer (PCa). However, the performance of these tools can change regarding the Prostate Imaging-Reporting and Data System (PI-RADS) categories. We compared three different tools: PSA density, MRI-ERSPC risk calculator and Proclarix in 567 men with suspected PCa (PSA. 22022-01-0120222022-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/292218https://dx.doi.org/urn:doi:10.3390/cancers14112702reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2922182026-06-06T12:50:31Z
dc.title.none.fl_str_mv Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
title Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
spellingShingle Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
Campistol i Torres, Miriam|||0000-0002-3212-3473
Clinically significant prostate cancer
PSA density
Proclarix
MRI-ERSPC
Magnetic resonance imaging
title_short Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
title_full Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
title_fullStr Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
title_full_unstemmed Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
title_sort Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
dc.creator.none.fl_str_mv Campistol i Torres, Miriam|||0000-0002-3212-3473
Morote Robles, Juan|||0000-0002-2168-323X
Triquell, Marina|||0000-0003-3881-8177
Regis, Lucas|||0000-0001-7121-1946
Celma, Ana|||0000-0002-3128-3811
de Torres, Inés|||0000-0002-5495-9140
Semidey Raven, Maria Eugenia|||0000-0001-8539-9265
Mast, Richard|||0000-0001-6005-800X
Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
Planas Morin, Jacques|||0000-0002-0222-584X
Trilla Herrera, Enrique|||0000-0001-9401-0872
author Campistol i Torres, Miriam|||0000-0002-3212-3473
author_facet Campistol i Torres, Miriam|||0000-0002-3212-3473
Morote Robles, Juan|||0000-0002-2168-323X
Triquell, Marina|||0000-0003-3881-8177
Regis, Lucas|||0000-0001-7121-1946
Celma, Ana|||0000-0002-3128-3811
de Torres, Inés|||0000-0002-5495-9140
Semidey Raven, Maria Eugenia|||0000-0001-8539-9265
Mast, Richard|||0000-0001-6005-800X
Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
Planas Morin, Jacques|||0000-0002-0222-584X
Trilla Herrera, Enrique|||0000-0001-9401-0872
author_role author
author2 Morote Robles, Juan|||0000-0002-2168-323X
Triquell, Marina|||0000-0003-3881-8177
Regis, Lucas|||0000-0001-7121-1946
Celma, Ana|||0000-0002-3128-3811
de Torres, Inés|||0000-0002-5495-9140
Semidey Raven, Maria Eugenia|||0000-0001-8539-9265
Mast, Richard|||0000-0001-6005-800X
Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
Planas Morin, Jacques|||0000-0002-0222-584X
Trilla Herrera, Enrique|||0000-0001-9401-0872
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Clinically significant prostate cancer
PSA density
Proclarix
MRI-ERSPC
Magnetic resonance imaging
topic Clinically significant prostate cancer
PSA density
Proclarix
MRI-ERSPC
Magnetic resonance imaging
description The selection of proper candidates for prostate biopsy after magnetic resonance imaging (MRI) has usually been studied in the overall population with suspected prostate cancer (PCa). However, the performance of these tools can change regarding the Prostate Imaging-Reporting and Data System (PI-RADS) categories. We compared three different tools: PSA density, MRI-ERSPC risk calculator and Proclarix in 567 men with suspected PCa (PSA.
publishDate 2022
dc.date.none.fl_str_mv 2
2022-01-01
2022
2022-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/292218
https://dx.doi.org/urn:doi:10.3390/cancers14112702
url https://ddd.uab.cat/record/292218
https://dx.doi.org/urn:doi:10.3390/cancers14112702
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421931526094848
score 15,811543

Similares en LA Referencia